SPAHLINGER SERUM
A MEDICAL VIEW. NOT SUFFICIENTLY TESTED. (By Telegraph—Press Assn.—Copyright.) LONDON, December 16. The Lancet (the official organ of the British Medical Association), in discussing an appeal on behalf of Professor Spahlinger and the optimistic reports of the treatment, says: New cures and fresh treatment of the disease are sometimes received by the daily Press and public with unguarded enthusiasm which bequeaths a legacy of disappointment to sufferers. Great expectations in pathology are not always realised. Even those prospective remedies of which high hopes have been justly formed may require a protracted period of proof or preparation before available to the ordinary patient. The Spahlinger treatment seems to. be passing through such a stage.
After detailing the fruitless negotiations between M. Spahlinger and the Ministry of Health, also the Red Cross, the Lancet asks: “Has M. Spahlinger yet produced an agent enabling us to tell a patient that payment of a definite sum will produce a definite benefit? Until any therapeutic agent has reached such a stage, we are surely not justified in promoting research on its behalf by appealing to the hopes and fears of patients seeking relief.”
Permanent link to this item
https://paperspast.natlib.govt.nz/newspapers/ST19231218.2.33
Bibliographic details
Southland Times, Issue 19125, 18 December 1923, Page 5
Word Count
190SPAHLINGER SERUM Southland Times, Issue 19125, 18 December 1923, Page 5
Using This Item
Stuff Ltd is the copyright owner for the Southland Times. You can reproduce in-copyright material from this newspaper for non-commercial use under a Creative Commons BY-NC-SA 3.0 New Zealand licence. This newspaper is not available for commercial use without the consent of Stuff Ltd. For advice on reproduction of out-of-copyright material from this newspaper, please refer to the Copyright guide.
Log in